Kateryna Krytska

4PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 06, 2026
Preclinical Activity of the B7-H3-Targeting Antibody-Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors.

Edward Favours, Haiying Tang, Peyton Wong

|Mar 04, 2025
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study.

Esther R Berko, Arlene Naranjo, Alexander A Daniels

|Feb 05, 2025
Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.

Smita Matkar, Michael P East, Timothy J Stuhlmiller

|Jul 31, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.

Liron D Grossmann, Chia-Hui Chen, Yasin Uzun

Pageof 1

Frequent Collaborators

4 joint publications

John M Maris

4 joint publications

Yael P Mossé

2 joint publications

Matthew Tsang

2 joint publications

Joshua R Kalna